Could Dry mRNA Vaccine Patches Eliminate the Cold Chain?
Discover how dry mRNA vaccine patches could reduce cold chain dependence, improve vaccine stability, and reshape pharmaceutical manufacturing and distribution.
“The pharma industry is beginning to look at biological age as a surrogate endpoint to improve clinical trials."
Explore expert-led podcasts, pharmaceutical intelligence, life sciences insights and research-driven analysis from leading industry voices. Pharmatica delivers trusted biotech news, drug development trends and commercial intelligence for professionals across the pharmaceutical sector.
Discover how dry mRNA vaccine patches could reduce cold chain dependence, improve vaccine stability, and reshape pharmaceutical manufacturing and distribution.
A recent systematic review reveals incredible detail about informed consent in clinical trials, participant understanding, and trial quality. Find out now.
Read about machine learning for lipid nanoparticle design used to improve cell, gene, and RNA drug delivery and help optimise next-generation therapeutics.
See how Anthropic's Gates Foundation partnership and Long-Term Benefit Trust could lead the way in shaping responsible AI governance across healthcare innovation.
Discover how AI/ML in sterile pharmaceutical manufacturing enables predictive maintenance, quality control, contamination detection, and intelligent GMP operations.
Learn how optimised clinical trial data collection improves data quality, reduces protocol and patient burden, and supports smarter clinical development.
Explore new benchmarking research on pharmaceutical R&D success rates, revealing why some drug pipelines consistently achieve higher approval rates than others.
LLM-assisted rare disease re-assessment improves genomic analysis, increasing diagnostic yield and supporting clinician-led precision medicine and possibly drug development.
Discover how modular pharmaceutical manufacturing and continuous production could improve flexibility, resilience, and efficiency across modern pharmaceutical operations.
The FAST-EU Pilot aims to accelerate multinational clinical trials through faster coordinated assessments, supporting Europe’s 2030 clinical research ambitions.
Discover why AI in cell and gene therapy is necessary for successful development by improving drug discovery, viral vector engineering, manufacturing, and quality control.
Can non-animal testing methods be used in preclinical drug discovery? Here is what the evidence is for their accuracy and limits assessing preclinical toxicity.